Paulo Fontoura.

No events began in the chosen period. Widen it, or reset.

• Sanofi Structural
  Abbott Laboratories and Sanofi confirmed the presence of fake vaccines circulating in Pakistan.
  Moves Paulo Fontoura

  Sun 16:28
• Hoffmann-La Roche Structural
  Major pharmaceutical companies licensed drug delivery technologies like Enhanze and Hypercon for various applications.
  Moves Paulo Fontoura

  Fri 16:54
• Sanofi Structural
  Sanofi advances Kymera's degrader candidate.
  Moves Paulo Fontoura

  Wed 19:26
• FDA Operational
  The FDA approved Miplyffa for the treatment of Niemann-Pick disease.
  Moves Paulo Fontoura

  Sat 00:55

• Sanofi Structural

  Sanofi formally employed Paulo Fontoura as EVP, Global Head of R&D Pharma.

  Some supportJun 28
  Paulo Fontoura → Sanofi

  Sanofi → Paulo Fontoura
• Hoffmann-La Roche Structural

  Paulo Fontoura was employed by Hoffmann-La Roche for 15 years.

  Some supportJun 23
  Paulo Fontoura → Hoffmann-La Roche

  Hoffmann-La Roche → Paulo Fontoura
• Sanofi Structural

  Paulo Fontoura holds an R&D head position at Sanofi.

  Some supportSep 21
  Paulo Fontoura → Sanofi

  Sanofi → Paulo Fontoura
• Houman Ashrafian Structural

  Paulo Fontoura is scheduled to replace Houman Ashrafian in R&D leadership.

  Some supportJun 28
  Paulo Fontoura → Houman Ashrafian

  Houman Ashrafian → Paulo Fontoura
• FDA Operational

  Paulo Fontoura's contributions influenced successful FDA and EMA regulatory approvals.

  Some supportJun 23
  Paulo Fontoura → FDA

  FDA → Paulo Fontoura